Titlebook: Soft Tissue Tumors; A Practical and Comp Simone Mocellin Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license

ENDOW

Book 2021es in terms of its epidemiology, pathology diagnosis, clinical behavior, therapy and biomarker pattern (of both diagnostic and therapeutic value). This book offers a practical, clearly structured reference guide, covering all of these aspects for each soft tissue tumor. Thanks to the consistent and

休息

細(xì)胞學(xué)

Definitiones, each one characterized by specific features in terms of epidemiology, pathology diagnosis, clinical behavior, therapy and biomarker pattern (of both diagnostic and therapeutic value). This textbook is designed as a practical reference covering all these areas for each single soft tissue tumor. T

圖畫文字

Etching

Biomarkers only for diagnostic purposes (where a single biomarker but more often a set of them are essential to make the correct diagnosis) but also to better define the biological behavior of the tumor (improving the risk stratification of patients) and to identify patients who can benefit of target therapie

結(jié)果

Prognosisl behavior is classified by the WHO into three categories: benign, intermediate (including forms that can locally recur and those at low risk of metastasis), and malignant (which are characterized by high risk of metastasis). Of note, some subtypes of soft tissue tumors classified among benign neopl

雇傭兵

GUMP

Definitionhe consistent and user friendly format will ease the access to the information needed by the reader, who is also provided with up-to-date and authoritative literature sources necessary to deepen any aspect of interest.

LARK

Prognosisasms can actually behave as tumors of intermediate malignant potential (e.g., cellular and atypical variants of benign fibrous histiocytoma). The present chapter is dedicated to describe the current modalities to determine soft tissue tumors’ prognosis.

加強(qiáng)防衛(wèi)